References
- Amoroso L. The second international conference on nutrition: implications for hidden hunger. World Rev. Nutr. Diet. 115, 142–152 (2016).
- Demaio AR, Branca F. Decade of action on nutrition: our window to act on the double burden of malnutrition. BMJ Glob. Heal. 3(Suppl 1), e000492 (2018).
- Bundy DAP, de Silva N, Horton S et al. Investment in child and adolescent health and development: key messages from Disease Control Priorities, 3rd Edition. Lancet 391(10121), 687–699 (2018).
- Roudi-Fahimi F, Kent MM. Challenges and opportunities–the population of the middle east and north africa. Popul. Bull. 62(2), 3–19 (2007).
- UNICEF. Progress for children with equity in the middle east and north Africa, 8–9 (2017). https://reliefweb.int/sites/reliefweb.int/files/resources/Progress_for_Children_in_MENA_Web.pdf.
- Galal O. Nutrition-related health patterns in the Middle East. Asia Pac. J. Clin. Nutr. 12(3), 337–343 (2003).
- UNICEF, WHO, Group WB. Levels and trends in child malnutrition. Jt. Child Malnutrition Estim. Ed., 11–12 (2017). https://data.unicef.org/wp-content/uploads/2017/05/JME-2017-brochure.pdf.
- Grantham-McGregor S, Cheung YB, Cueto S et al. Developmental potential in the first 5 years for children in developing countries. Lancet 369(9555), 60–70 (2007).
- Home – ClinicalTrials.gov (www.clinicaltrials.gov/).
- Zarin DA, Williams RJ, Tse T, Ide NC. The role and importance of clinical trial registries and results databases. In: Principles and Practice of Clinical Research (4th Ed.). Gallin JI, Ognibene FP, Johnson LL ( Eds). Academic Press, London, UK, 111–125 (2017).
- World Medical Association. World medical association declaration of Helsinki. Ethical principles for medical research involving human subjects. J. Am. Med. Assoc. 310(20), 2191–2194 (2013).
- Welch RW, Antoine JM, Berta JL et al. Guidelines for the design, conduct and reporting of human intervention studies to evaluate the health benefits of foods. Br. J. Nutr. 106(Suppl), S3–S15 (2011).
- Rajadhyaksha V. Conducting feasibilities in clinical trials: an investment to ensure a good study. Perspect. Clin. Res. 1(3), 106–109 (2010).
- WHO. Regional office for the eastern mediterranean. Regional strategy on nutrition 2010–2019 and plan of action. 6–9. http://apps.who.int/iris/bitstream/handle/10665/116694/dsa1230.pdf?sequence=1&isAllowed=y.
- Hwalla N, Al Dhaheri AS, Radwan H et al. The prevalence of micronutrient deficiencies and inadequacies in the Middle East and approaches to interventions. Nutrients 9(3), 229 (2017).
- Misik V. Shifting sands. Eur. Pharm. Contract. Autumn 2011, 66–70 (2011).
- Worsley SD, Oude Rengerink K, Irving E et al. Series: pragmatic trials and real world evidence: paper 2. Setting, sites, and investigator selection. J. Clin. Epidemiol. 88, 14–20 (2017).
- Glickman SW, McHutchison JG, Peterson ED et al. Ethical and scientific implications of the globalization of clinical research. N. Engl. J. Med. 360(8), 816–823 (2009).
- Hay M, Thomas DW, Craighead JL, Economides C, Rosenthal J. Clinical development success rates for investigational drugs. Nat. Biotechnol. 32(1), 40–51 (2014).
- Smietana K, Siatkowski M, M⊘ller M. Trends in clinical success rates. Nat. Rev. Drug Discov. 15(6), 379–380 (2016).
- Fountzilas E, Said R, Tsimberidou AM. Expanded access to investigational drugs: balancing patient safety with potential therapeutic benefits. Expert Opin. Investig. Drugs 27(2), 155–162 (2018).
- Day C, Jackson A. Main review findings. Rev. Nutr. Hum. Heal. Res. 7–8 (2017). https://mrc.ukri.org/documents/pdf/review-of-nutrition-and-human-health/.